Becker JC - Search Results

1

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19.

Gambichler T, Reuther J, Scheel CH, Becker JC. Gambichler T, et al. Among authors: becker jc. J Immunother Cancer. 2020 Jul;8(2):e001145. doi: 10.1136/jitc-2020-001145. J Immunother Cancer. 2020. PMID: 32611687 Free PMC article. Review.

2

MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.

Ugurel S, Spassova I, Wohlfarth J, Drusio C, Cherouny A, Melior A, Sucker A, Zimmer L, Ritter C, Schadendorf D, Becker JC. Ugurel S, et al. Among authors: becker jc. Cancer Immunol Immunother. 2019 Jun;68(6):983-990. doi: 10.1007/s00262-019-02341-9. Epub 2019 Apr 16. Cancer Immunol Immunother. 2019. PMID: 30993371 Free PMC article.

3

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C. Becker JC, et al. J Dtsch Dermatol Ges. 2019 May;17(5):562-576. doi: 10.1111/ddg.13841. Epub 2019 May 6. J Dtsch Dermatol Ges. 2019. PMID: 31056838

4

S2k-Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) - Update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C. Becker JC, et al. J Dtsch Dermatol Ges. 2019 May;17(5):562-577. doi: 10.1111/ddg.13841_g. J Dtsch Dermatol Ges. 2019. PMID: 31115985

5

Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?

Zaremba A, Chorti E, Jockenhöfer F, Bolz S, Sirin S, Glas M, Becker JC, Ugurel S, Roesch A, Schadendorf D, Livingstone E, Hagenacker T, Zimmer L. Zaremba A, et al. Among authors: becker jc. J Immunother Cancer. 2019 May 29;7(1):141. doi: 10.1186/s40425-019-0626-9. J Immunother Cancer. 2019. PMID: 31142383 Free PMC article.

6

A Brief Communication on Circulating PD-1-positive T-Regulatory Lymphocytes in Melanoma Patients Undergoing Adjuvant Immunotherapy With Nivolumab.

Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC. Gambichler T, et al. Among authors: becker jc. J Immunother. 2019 Sep;42(7):265-268. doi: 10.1097/CJI.0000000000000277. J Immunother. 2019. PMID: 31145230

7

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases.

Angela Y, Haferkamp S, Weishaupt C, Ugurel S, Becker JC, Oberndörfer F, Alar V, Satzger I, Gutzmer R. Angela Y, et al. Among authors: becker jc. Cancer Immunol Immunother. 2019 Jul;68(7):1187-1194. doi: 10.1007/s00262-019-02353-5. Epub 2019 Jun 11. Cancer Immunol Immunother. 2019. PMID: 31187176 Free PMC article.

8

MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma.

Fan K, Gravemeyer J, Ritter C, Rasheed K, Gambichler T, Moens U, Shuda M, Schrama D, Becker JC. Fan K, et al. Among authors: becker jc. J Invest Dermatol. 2020 Jan;140(1):56-65.e3. doi: 10.1016/j.jid.2019.06.135. Epub 2019 Jul 5. J Invest Dermatol. 2020. PMID: 31283928 Free article.

9

Dicer Sequencing, Whole Genome Methylation Profiling, mRNA and smallRNA Sequencing Analysis in Basal Cell Carcinoma.

Sand M, Bromba A, Sand D, Gambichler T, Hessam S, Becker JC, Stockfleth E, Meyer T, Bechara FG. Sand M, et al. Among authors: becker jc. Cell Physiol Biochem. 2019;53(5):760-773. doi: 10.33594/000000171. Cell Physiol Biochem. 2019. PMID: 31647206 Free article.

10

Expression of Programmed Cell Death Proteins in Kaposi Sarcoma and Cutaneous Angiosarcoma.

Gambichler T, Koim S, Wrobel M, Käfferlein HU, Brüning T, Stockfleth E, Becker JC, Lang K. Gambichler T, et al. Among authors: becker jc. J Immunother. 2020 Jun;43(5):169-174. doi: 10.1097/CJI.0000000000000317. J Immunother. 2020. PMID: 32224717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

647 results

Search Page